59 results
8-K
EX-99.1
COGT
Cogent Biosciences Inc
26 Feb 24
Cogent Biosciences Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results
8:30am
positive clinical data from the Phase 2 SUMMIT and APEX trials at the American Society of Hematology (ASH) annual meeting. Highlights from APEX … in patients with GIST at the Connective Tissue Oncology Society (CTOS) annual meeting. Positive lead-in data was first presented at the 2023 American
8-K
COGT
Cogent Biosciences Inc
11 Dec 23
Other Events
8:04am
trial evaluating bezuclastinib in patients with nonadvanced systemic mastocytosis (“NonAdvSM”) at the 65th American Society of Hematology (“ASH 2023
8-K
EX-99.1
aapope 1wqh2w81u3z
2 Nov 23
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2023 Financial Results
9:18am
424B5
amhdqgv mywpr4g
8 Jun 23
Prospectus supplement for primary offering
4:01pm
424B5
z5stbg8 kt32zq1tla
6 Jun 23
Prospectus supplement for primary offering
5:22pm
8-K
o5jk6wupmz5kbajte
6 Jun 23
Other Events
4:03pm
8-K
EX-99.1
zdq3edyla7mh4dsc mj
9 May 23
Cogent Biosciences Reports Recent Business Highlights and First Quarter
8:13am
8-K
EX-99.2
384zqf fdk70f5
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
4twl jkp13i5f20b2bn
12 Dec 22
Cogent Biosciences Announces Positive Updated Clinical Data from Ongoing Phase 2 APEX Trial Evaluating
8:03am
8-K
EX-99.1
bkoe5gkf2h52m 1k1tnc
14 Nov 22
Cogent Biosciences Reports Recent Business Highlights and Third Quarter 2022 Financial Results
7:14am